For those struggling with Parkinson’s Disease, sleep issues can often be one of the most frustrating symptoms.
— Photopharmics Team
SALT LAKE CITY, UTAH, UNITED STATES, March 28, 2022 /EINPresswire.com/ — When most people think of Parkinson’s Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinson’s experience a wide range of non-motor symptoms that can often be more disruptive to their daily lives. Several of the most common non-motor complaints are associated with sleep issues. We all need sleep for our bodies to revitalize and repair as well as for productive days. For people with PD, achieving regular, healthy sleep and staying alert the next day are among the many problems associated with the disease.
Over 75 percent of people with PD report these issues. These can come from a variety of sources. Parkinson’s itself can cause sleep disruptions and contribute to daytime fatigue, while many PD medications can often aggravate these problems. This lack of restorative sleep can affect patients’ quality of life and also their bodies’ ability to manage PD. Daytime fatigue further impedes personal productivity and reduces social interactions.
The following is a list from Parkinson’s.org of the most common sleep issues people with Parkinson’s face
– Difficulty falling and staying asleep
Excessive daytime sleepiness
– Talking or yelling out while asleep
– Vivid dreaming
– Leg movements, jerking, cramping (restless leg syndrome)
– Difficulty turning over in bed
– Waking up to go to the bathroom
Experts advocate several things that to help people with PD get a better night’s sleep. First, make sure to have a consistent sleeping schedule. Plan to get around eight hours of sleep a night. Go to bed around the same time each night and wake up (or get out of bed) at similar times in the morning. It can also help to have a bedtime routine (drinking water, brushing teeth, etc.) to help prepare the body for sleep.
Second, night-time sleep quality can be affected by what is done during the day. Experts recommend daily exercise and spending time outside if possible. While this may be difficult for some, exposure to sunlight is also recommended. PhotoPharmics is finalizing plans for a pivotal clinical trial of a FDA Breakthrough therapeutic device, Celeste®. The aim of this trial is to confirm the high levels of relief for non-motor symptoms for people with PD from specialized phototherapy. To learn more and receive updates about this clinical trial or other details about PhotoPharmics, visit photopharmics.com.
PhotoPharmics is a privately held, clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the eyes. Company founders have 30+ years of research and experience in this field. They previously developed specialized light solutions now widely used to regulate circadian rhythms in seasonal affective disorder, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007).
Drawing from research and recent trials, PhotoPharmics is developing applications of specialized light across several neurodegenerative diseases. The company aims to make a clinically meaningful difference in patients’ lives by delivering safe and effective non-invasive treatments. Investor inquiries are welcomed. Learn more at www.photopharmics.com.
email us here